16 September 2025 – Animal Wellness Investments S.p.A., an independently managed investment subsidiary of Investindustrial VIII SCSp (“Investindustrial”), has finalised an agreement to invest in Fatro Group (“Fatro” or the “Group”), a leading Italian company in the veterinary pharmaceutical sector, operating in the production of medicines and vaccines dedicated to animal health and well-being.
Founded in 1947 by Gualtiero and Corrado Zaini and headquartered in Ozzano dell’Emilia (BO), the Group is a leader in the animal health sector, specialised in the research, development, production and commercialisation of a wide range of pharmaceutical products, vaccines and other solutions for the treatment and prevention of diseases in both pet and farm animals.
In 2024, the Group recorded revenues of approximately €220 million. Fatro has a significant international presence, serving customers in over 90 countries and operating through subsidiaries in Turkey, Spain, Greece, Poland, the Czech Republic, Argentina, Uruguay and India. The Group employs around 870 people and has two production sites in Italy, located in Ozzano dell’Emilia (BO) and Maclodio (BS).
As part of this partnership, Mrs. Silvana Dal Magro – who will retain a significant stake in the Group alongside Investindustrial – will continue to serve as Chief Executive Officer, with the goal of further strengthening Fatro’s leadership position and accelerating its international growth, supported by Investindustrial’s track record in helping high-quality family-owned mid-market companies expand globally.
Andrea C. Bonomi, Chairman of the Investindustrial Advisory Board, commented: “Investindustrial continues to be the partner of choice for high-quality, family-owned Italian businesses led by entrepreneurs seeking to take their companies to the next level of growth. We were extremely impressed by Fatro’s strong performance, market leadership and outstanding reputation, and we are excited to work alongside Silvana Dal Magro and the entire management team to help Fatro grow its leadership both in the Italian market and internationally. Investindustrial’s strong track record in successfully supporting family-owned businesses, combined with its industrial approach and global network, was a key factor in establishing this partnership, aimed at further growing a long-standing European leader in the veterinary sector.”
Silvana Dal Magro, Chairman and Chief Executive Officer of Fatro, said: “I am extremely proud of the journey started by our late Founder, Dr. Corrado Zaini, and carried forward by myself, which has enabled Fatro Group —thanks also to the valuable contribution of all our employees and people — to establish itself as one of the leading players in the veterinary pharmaceutical sector. I am confident that the partnership with Investindustrial will allow Fatro Group to continue its growth path, with the promotion and growth of its people as one of its key strategic pillars.”
This transaction strengthens Investindustrial’s track record in executing strategic partnerships with families and entrepreneurs in the mid-market segment, as well as its focus on investments in high-quality health and manufacturing companies that are leaders in niche markets — which currently represent approximately 70% of Investindustrial’s deployed capital. Examples include Ourvita (nutraceuticals and wellness product manufacturing), Arterex (medical components and products), Fassi (lifting equipment), CEME (precision technologies for fluid control), Guala Closures (specialty closures for spirits and beverages), Omnia Technologies (automation for the beverage and pharmaceutical sectors) and Piovan (industrial automation in the auxiliary machinery segment).
In the transaction, Investindustrial was assisted by BofA Securities and L.F. Advisory (financial advisors), Studio Chiomenti (legal), BCG and Stonehaven Consulting (commercial), PwC (accounting and tax), Ramboll (environmental) and WTW (insurance).
The shareholders of the Fatro Group were assisted by Capex and Proactiva (financial advisors), KPMG (accounting), PedersoliGattai and Osborne Clarke (legal), and Stantec (environmental).
About Investindustrial
Investindustrial is a leading European group of independently managed investment, holding and advisory companies with €17 billion of raised fund capital. With ESG principles deeply embedded into the firm’s core approach, Investindustrial has a 35-year history of providing mid-market companies with capital, industrial expertise, operational focus and global platforms to accelerate sustainable value creation and international expansion. Certain companies of the Investindustrial group are authorised by, and subject to regulatory supervision of the FCA in the United Kingdom, the CSSF in Luxembourg and the FSRA in Abu Dhabi Global Market. References to ‘Investindustrial’ are of generic nature, for ease of reading and may refer, depending on the context, to a fund or any of its independently managed subsidiaries. Investindustrial’s investment companies act independently from each other and each Investindustrial fund.
Additional information is available at www.investindustrial.com.
For further information please contact
H/Advisors Maitland (UK / international)
David Sturken
Mob +44 (0) 7990 595 913
david.sturken@h-advisors.global
Jonathan Cook
Mob +44 (0) 7730 777 865
